Is Mazda a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Mazda Ltd is a good quality company .

Is Mazda undervalued or overvalued?

The key valuation ratios of Mazda Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Mazda share price return in the past 10 years?

Mazda Ltd share price has appreciated 18% annually (CAGR) over the past ten years.

Is Mazda a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Mazda Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

Mazda Ltd - Stock Valuation and Financial Performance

Name: Mazda
Brand: Mazda

BSE: 523792 | NSE: MAZDA | Engineering - Industrial Equipments | Small Cap

Place order

Mazda Share Price

₹1,464.60 -27.00 -1.81%
as on 20-Dec'24 16:59

10 Year X-Ray of Mazda:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	18.3%	18.2%	13.9%	12.1%	14.6%	17.4%	16.3%	18.2%	20.8%	21.3%	-
Value Creation Index ⓘ	0.3	0.3	0.0	-0.1	0.1	0.2	0.2	0.3	0.5	0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	118	122	110	107	139	180	152	165	192	225	204
Sales YoY Gr.	-	3.6%	-9.5%	-2.7%	29.1%	29.6%	-15.2%	8.3%	16.1%	17.7%	-
Adj EPS ⓘ	24.7	26.4	30.6	17.6	27.6	40.1	39.4	51.4	65.7	75.9	73.7
YoY Gr.	-	7%	15.9%	-42.6%	56.6%	45.4%	-1.7%	30.5%	28%	15.4%	-
BVPS (₹) ⓘ	213.4	233.7	277.1	292.9	315.5	329.2	368.1	409.6	464.2	529.9	542.7
Adj Net Profit ⓘ	10.5	11.3	13	7.5	11.7	16	15.8	20.6	26.3	30.4	29
Cash Flow from Ops. ⓘ	15.7	17.3	7.3	13.6	-5.1	22.3	20	8.4	23.6	43	-
Debt/CF from Ops. ⓘ	0.2	0.1	0.3	0.2	-0.4	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	7.5%	10.2%	13.9%	17.7%
Adj EPS ⓘ	13.3%	22.5%	24.4%	15.4%
BVPSⓘ	10.6%	10.9%	12.9%	14.2%
Share Price	18%	30.3%	34.4%	18.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	12.1	11.8	12	6.2	9.1	12.1	11.3	13.2	15.1	15.3	13.7
Op. Profit Mgn % ⓘ	14.7	15.3	12	13.1	13.5	14	15.5	16.7	19.6	17.7	16.2
Net Profit Mgn % ⓘ	8.9	9.2	11.8	7	8.5	8.9	10.3	12.5	13.8	13.5	14.4
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	170	156	165	172	174	165	174	162	169	137	131
Cash Conv. Cycle ⓘ	77	70	79	94	88	91	112	112	116	94	110

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 13.93%

Net Profit is growing at healthy rate in last 3 years 24.44%

Return on Equity has declined versus last 3 years average to 13.70%

Sales growth is not so good in last 4 quarters at -7.04%

Latest Financials - Mazda Ltd.

	Standalone	Consolidated
TTM EPS (₹)	73.7	-
TTM Sales (₹ Cr.)	204	-
BVPS (₹.) ⓘ	542.7	-
Reserves (₹ Cr.) ⓘ	220	-
P/BV ⓘ	2.70	-
PE ⓘ	19.88	-

From the Market
52 Week Low / High (₹)	1087.30 / 1650.20
All Time Low / High (₹)	2.00 / 1650.20
Market Cap (₹ Cr.)	587
Equity (₹ Cr.)	4
Face Value (₹)	10
Industry PE ⓘ	59.3

Management X-Ray of Mazda:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Mazda

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Mazda

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	118	122	110	107	139	180	152	165	192	225
Operating Expenses ⓘ	101	104	97	93	120	155	129	137	154	186
Manufacturing Costs	16	20	16	14	18	20	18	20	22	23
Material Costs	61	60	57	54	76	104	80	81	93	116
Employee Cost	13	14	13	13	15	17	18	21	24	27
Other Costs ⓘ	11	10	11	11	12	13	12	15	15	20
Operating Profit ⓘ	17	18	13	14	19	25	24	28	37	40
Operating Profit Margin (%)	14.6%	14.7%	11.9%	13.0%	13.5%	14.0%	15.5%	16.7%	19.4%	17.6%
Other Income ⓘ	1	2	5	4	3	2	2	3	2	7
Interest ⓘ	0	1	0	1	1	1	1	1	1	1
Depreciation ⓘ	2	2	3	3	3	3	3	2	3	4
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	16	17	15	14	19	22	22	28	36	42
Tax ⓘ	5	5	2	4	4	6	6	6	9	10
Profit After Tax	11	12	13	10	14	17	16	21	27	32
PAT Margin (%)	9.5%	9.9%	11.7%	9.6%	10.2%	9.3%	10.7%	12.9%	13.9%	14.0%
Adjusted EPS (₹)	26.4	28.3	30.3	24.2	33.1	41.6	40.8	53.0	66.5	78.7
Dividend Payout Ratio (%)	23%	23%	24%	34%	27%	24%	27%	23%	21%	20%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	91	100	118	125	134	132	147	164	186	212
Share Capital ⓘ	4	4	4	4	4	4	4	4	4	4
Reserves ⓘ	87	95	114	120	130	128	143	160	182	208
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	3	2	2	3	2	1	0	0	0	0
Long Term Debt	0	0	0	0	0	1	0	0	0	0
Short Term Debt	3	2	2	3	1	0	0	0	0	0
Trade Payables	12	13	11	14	23	19	12	16	18	14
Others Liabilities ⓘ	17	18	9	10	14	16	13	12	20	14
Total Liabilities ⓘ	123	132	141	151	173	167	173	192	224	240
Fixed Assets
Gross Block	33	36	50	54	56	58	62	54	97	98
Accumulated Depreciation	12	14	16	19	22	25	27	22	24	27
Net Fixed Assetsⓘ	21	23	34	34	34	33	35	32	73	72
CWIP ⓘ	0	3	4	4	8	17	25	40	0	0
Investmentsⓘ	33	41	47	57	43	28	40	31	43	78
Inventories	20	19	18	20	37	38	29	35	53	36
Trade Receivables	22	23	23	25	30	33	32	42	37	33
Cash Equivalents	11	10	3	6	5	10	7	5	8	14
Others Assetsⓘ	16	14	12	5	16	8	5	8	10	8
Total Assets ⓘ	123	132	141	151	173	167	173	192	224	240

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	16	17	7	14	-5	22	20	8	24	43
PBT ⓘ	16	17	15	14	19	22	22	28	36	42
Adjustment ⓘ	1	2	-1	2	1	4	2	0	3	1
Changes in Working Capital ⓘ	3	4	-3	0	-19	2	3	-14	-8	11
Tax Paid ⓘ	-5	-5	-3	-3	-5	-6	-7	-5	-7	-11
Cash Flow From Investing Activity ⓘ	-9	-17	-10	-7	10	4	-20	-5	-15	-30
Capex	-4	-7	-15	-1	-7	-13	-10	-16	-5	-3
Net Investments	-5	-10	5	-6	16	16	-10	11	-10	-28
Others ⓘ	0	1	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	-4	-4	-4	-4	-9	-19	-2	-6	-6	-6
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	-1	-1	-1	-1	-1	-1	-1
Dividend Paid ⓘ	-2	-3	-3	-3	-3	-7	-1	-4	-5	-6
Others ⓘ	-1	-2	0	0	-5	-11	0	-1	0	0
Net Cash Flow ⓘ	3	-4	-7	3	-4	7	-2	-3	3	6

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	12.9	12.65	11.88	8.49	10.88	12.51	11.69	13.64	15.22	15.83
ROCE (%)	18.31	18.23	13.92	12.14	14.64	17.4	16.25	18.15	20.78	21.27
Asset Turnover Ratio	1.06	1.04	0.88	0.74	0.86	1.06	0.9	0.91	0.92	0.98
PAT to CFO Conversion(x)	1.45	1.42	0.54	1.4	-0.36	1.29	1.25	0.38	0.89	1.34
Working Capital Days
Receivable Days	64	62	69	80	72	64	77	81	74	56
Inventory Days	64	53	56	64	75	77	80	70	83	72
Payable Days	80	77	76	84	89	74	70	62	67	51

Mazda Ltd Stock News

Mazda Ltd FAQs

What is the share price of Mazda?

Company share prices are keep on changing according to the market conditions. The closing price of Mazda on 20-Dec-2024 16:59 is ₹1,464.6.

What is the market cap of Mazda?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Mazda stood at ₹586.6.

What is the P/E ratio of Mazda?

The latest P/E ratio of Mazda as of 20-Dec-2024 16:59 is 19.88.

What is the P/B ratio of Mazda?

The latest P/B ratio of Mazda as of 20-Dec-2024 16:59 is 2.70.

What is the 52-week high and low of Mazda?

The 52-week high of Mazda is ₹1,650.2 and the 52-week low is ₹1,087.3.

What is the TTM revenue of Mazda?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Mazda is ₹204.5 ( Cr.) .

About Mazda Ltd

Mazda Ltd. was established in 1977, as a small unit in western India with the objective of manufacturing automated valve packages. Over the years, it gradually expanded its operations and marketing, taking care to instil the highest levels of quality in all its products, with near-obsessive attention to details and customers satisfaction.

Over the years, its quest for further growth led to an equity participation and technical collaboration with market leaders Croll-Reynolds Inc., USA, in the field of vacuum systems and air pollution control equipment.

In time, the company extended into a second international collaboration with Germany-based Kauer Engineering for Turbine Bypass Valves, followed by a consolidation of its technological strengths to diversify into Evaporators and Crystallisers.

Today two decades down the road, Mazda Ltd has come long way. It has clearly established itself, in domestic and global markets, as a pioneer and leader in its chosen fields, offering the finest â€œin specialised, high valueâ€ products.

In its new growth phase, the company is now radically diversifying into the high-potential sunrise industry, Biotechnology in the field of carbohydrates, rare sugars and miscellaneous bio-chemicals.

Different divisions of the company:

Engineering Division

It specialises in supplying equipments to various industries like power, fertilizers, chemicals and bulk drugs industries. It also caters to the needs of refineries, sugar and food, pulp and paper and others. Mazda Limited has built a strategic alliance with Croll-Reynolds Inc. USA (C-R), who is a major shareholder in Mazda Controls. Croll-Reynolds has shared a substantial amount of technology with Mazda. At its facilities in Ahmedabad, Mazda and Croll-Reynolds work together to design, manufacture and test high quality equipments for sale to all the regions of the world.

Biochemical Division

Special Sugars- Glycals are sophisticated Chiral building blocks that can be used in chemical, enzymatic and combinatorial synthesis of natural and unnatural complex carbohydrates, oligosaccharide and glycoconjugate targets for advanced research in the pharmaceutical and biotechnology industries. Carbohydrates are key elements in various molecular signaling and recognition process at the cellular level in all living organisms. They also play central role in human immune system, and are important in the onset of illness and disease.

Product range of the company includes: